miRNA biomarker

NEW YORK (GenomeWeb News) – An investigator at the Cedars-Sinai Oschin Comprehensive Cancer Institute has landed a $300,000 in funding from the Avon Foundation for Women to study blood-based biomarkers that could be used to treat and stratify breast cancer patients.

NEW YORK (GenomeWeb News) – The National Institutes of Health said today that it has awarded $17 million to fund 24 new research projects seeking to understand how extracellular RNA is involved in communication between cells and how they may be used as biomarkers for diseases.

NEW YORK (GenomeWeb News) – The Institute of Cancer Research, London has granted Oxford Gene Technology a license to develop a panel of diagnostic and prognostic prostate cancer microRNA biomarkers into a new assay, OGT said today.

NEW YORK (GenomeWeb News) – MicroRNA markers in the blood may hold promise as a means of predicting ill health effects following exposure to ionizing radiation, according to a PLOS One study based on

By targeting a subclass of metastatic breast cancer cells called cancer stem-like cells, a team led by researchers at the Southern Illinois University School of Medicine has found a microRNA, miR-7, that appears to play a key role in brain-specific breast cancer metastasis.

NEW YORK (GenomeWeb News) – EMD Millipore today said it is jointly developing a microRNA biomarker-based monitoring methodology with Sistemic for the consistent growth of stem cells in EMD Millipore's Mobius CellReady platform.

NEW YORK (GenomeWeb News) – Regulus Therapeutics, a developer of microRNA-based therapeutics, announced after the close of the market Wednesday that it has signed a deal with Biogen Idec to identify blood-borne miRNA biomarkers for multiple sclerosis.

NEW YORK (GenomeWeb News) –Genisphere and the Lankenau Institute for Medical Research today said that they have expanded their research collaboration aimed at identifying microRNA biomarkers to include Crohn's Disease and other inflammatory bowel disorders.

Blood levels of the microRNA miR-625-3p could serve as a predictive biomarker for the early diagnosis of malignant pleural mesothelioma, according to research by a group from the Concord Hospital Asbestos Diseases Research Institute in Sydney, Australia.

Pages

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.